The global Large Language Models in Healthcare market size was valued at USD 1542.6 million in 2025 and is projected to reach USD 26917.4 million by 2035, expanding at a CAGR of 33.1% from 2026 to 2035. Market growth is supported by increasing adoption of healthcare AI assistants, clinical automation platforms, and generative AI-powered decision support.
|
Years |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
Revenue (USD Mn) |
654.2 |
XX |
XX |
1542.6 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
26917.4 |
|
Region |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
North America |
XX |
XX |
XX |
880.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
13010.2 |
|
Europe |
XX |
XX |
XX |
316.2 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
4852.4 |
|
Asia Pacific |
XX |
XX |
XX |
262.2 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
5311.9 |
|
Latin America |
XX |
XX |
XX |
37 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
631.6 |
|
Middle East & Africa |
XX |
XX |
XX |
46.2 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
748.8 |
|
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
|
Conservative |
1134.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
17149.7 |
|
Likely |
1542.6 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
26917.4 |
|
Optimistic |
1134.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
26239.3 |
Healthcare providers worldwide are increasingly adopting large language models (LLMs) to reduce administrative workloads and improve clinician efficiency. According to the American Medical Association (AMA), 41.9% of physicians reported experiencing at least one symptom of burnout in 2025, highlighting the ongoing strain on healthcare professionals. Administrative tasks, documentation requirements, and EHR-related workloads remain among the leading contributors to physician dissatisfaction and burnout. The AMA further notes that excessive documentation and after-hours EHR work continue to consume significant physician time, reducing direct patient interaction and care quality.
The growing documentation burden is creating substantial demand for AI-powered medical scribes, ambient documentation platforms, and automated clinical note-generation solutions powered by LLMs. Research published by the U.S. National Institutes of Health (NIH) indicates that documentation burden is a major contributor to clinician burnout, with greater EHR usage and administrative workloads strongly associated with lower job satisfaction and increased burnout risk. Additionally, a 2025 JAMA Network Open study found that ambient documentation technologies reduced clinician documentation burden and improved well-being among healthcare professionals. These trends are encouraging hospitals and healthcare systems to invest in generative AI solutions that automate clinical documentation, streamline workflows, and allow physicians to spend more time on patient care rather than administrative tasks.
The rapid adoption of electronic health records (EHRs) is creating a strong technological foundation for the deployment of large language models across healthcare organizations. According to the U.S. Office of the National Coordinator for Health Information Technology (ONC), nearly 96% of non-federal acute care hospitals and 78% of office-based physicians had adopted certified EHR systems by 2021. More recent data from the CDC's National Electronic Health Records Survey (NEHRS) reported that 95.0% of U.S. office-based physicians had adopted EHR systems in 2024, demonstrating the widespread digitization of healthcare information.
The availability of large volumes of structured and unstructured clinical data within EHR systems is enabling healthcare providers to deploy LLMs for clinical documentation, decision support, patient communication, coding assistance, and workflow automation. A 2025 study published in JAMA Network Open reported that more than half of U.S. hospitals either currently use generative AI integrated with their EHR systems (31.5%) or plan to implement such capabilities within the following year (24.7%). This rapid integration of generative AI into existing healthcare IT ecosystems is significantly expanding the addressable market for healthcare-focused LLM solutions. As healthcare organizations continue investing in digital transformation initiatives, the convergence of EHR infrastructure and generative AI technologies is expected to remain a major catalyst for market growth.
The adoption of large language models in healthcare is constrained by growing concerns surrounding patient data privacy, cybersecurity risks, and regulatory compliance requirements. Healthcare organizations manage highly sensitive patient information, making AI deployment subject to stringent regulations such as HIPAA in the United States and GDPR in Europe. According to a report highlighted by HIMSS, healthcare providers continue to face significant challenges in securing clinical data as AI adoption expands across healthcare systems. Furthermore, a recent healthcare cybersecurity analysis reported that a record 275 million healthcare records were breached in 2024, emphasizing the increasing vulnerability of healthcare data environments. These security concerns create hesitation among hospitals and healthcare organizations when deploying LLM-powered applications that require access to large volumes of patient data.
Academic and healthcare publications also identify data governance and privacy protection as major barriers to AI implementation. Research published in the National Library of Medicine highlights that AI-driven healthcare systems face persistent challenges related to data sharing, patient consent, data ownership, and privacy preservation. Similarly, a 2025 healthcare AI readiness survey found that while 85% of healthcare leaders were exploring or adopting generative AI capabilities, 91% did not feel very prepared to implement AI responsibly, largely due to governance, privacy, and compliance concerns. These challenges increase implementation complexity, elevate operational costs, and slow the widespread adoption of LLM technologies across healthcare institutions.
Clinical reliability remains one of the most significant restraints affecting the adoption of large language models in healthcare. Although LLMs demonstrate strong capabilities in documentation, medical literature analysis, and workflow automation, they can still generate inaccurate, fabricated, or misleading outputs known as "hallucinations." Research published in Nature Digital Medicine found that healthcare LLMs remain susceptible to false factual generation and adversarial hallucinations in clinical settings, raising concerns regarding patient safety and treatment decisions. Healthcare organizations therefore require extensive validation, human oversight, and regulatory review before integrating LLMs into clinical decision-making workflows.
Recent studies continue to demonstrate the limitations of current AI systems in healthcare environments. Research reported in The Lancet Digital Health showed that AI models accepted fabricated medical information approximately 32% of the time, with acceptance rates increasing to nearly 47% when misinformation appeared in falsified hospital records. Additionally, an evaluation published in JAMA Network Open found that consumer AI chatbots misdiagnosed more than 80% of early-stage medical cases when patient information was incomplete, highlighting challenges in clinical reasoning and diagnostic accuracy. These concerns have led healthcare providers, regulators, and medical associations to emphasize human oversight and evidence-based validation before deploying LLMs in patient-facing applications. As a result, concerns regarding accuracy, accountability, and patient safety continue to slow broader healthcare adoption.
The rapid expansion of AI-enabled healthcare infrastructure is creating significant opportunities for large language model (LLM) adoption across hospitals, diagnostic centers, and life sciences organizations. Regulatory agencies and healthcare authorities are increasingly supporting responsible AI integration, helping accelerate innovation. According to the U.S. Food and Drug Administration (FDA), the number of AI-enabled medical devices authorized for marketing has increased dramatically over recent years. Industry analyses of FDA data indicate that more than 1,200 AI-enabled medical devices had received authorization by 2025, reflecting strong momentum in healthcare AI deployment and growing confidence in AI-driven healthcare technologies. Furthermore, FDA authorizations increased substantially between 2020 and 2025, demonstrating expanding acceptance of AI-powered clinical solutions.
Simultaneously, governments and healthcare organizations worldwide are investing in digital health transformation programs that provide the infrastructure required for healthcare LLM deployment. The World Health Organization (WHO) has identified AI as a key enabler for improving healthcare accessibility, efficiency, and sustainability while encouraging the development of safe and equitable AI ecosystems. Growing regulatory clarity, combined with expanding cloud infrastructure, healthcare interoperability initiatives, and electronic health record integration, is expected to create favorable conditions for next-generation healthcare LLM solutions. As healthcare providers continue modernizing clinical workflows, opportunities are emerging for vendors offering clinical copilots, medical documentation automation, patient engagement assistants, and AI-powered decision-support systems.
|
By Application |
2025 |
|
Clinical Documentation & Ambient AI |
28.7% |
|
Clinical Decision Support |
21.4% |
|
Administrative & Revenue Cycle Management |
17.6% |
|
Patient Engagement & Virtual Assistants |
15.3% |
|
Drug Discovery & Life Sciences |
12.8% |
|
Others |
4.2% |
The Software and GPT Platform segment dominated the Large Language Models in Healthcare Market due to increasing adoption of AI-powered clinical documentation, decision support systems, medical coding automation, and patient engagement platforms. Healthcare providers are prioritizing scalable software solutions that integrate with electronic health records, improve workflow efficiency, and enhance clinical productivity while reducing administrative burdens.
The Services segment is projected to witness the fastest growth during the forecast period, driven by rising demand for implementation, integration, customization, training, and compliance support. As healthcare organizations deploy LLM-based solutions across diverse clinical environments, the need for consulting, validation, maintenance, and regulatory guidance services continues to expand, accelerating segment growth.
The Clinical Documentation & Ambient AI segment accounted for the largest share of the Large Language Models in Healthcare Market owing to the growing adoption of AI medical scribes, automated note generation, and physician workflow automation tools. Healthcare providers are increasingly deploying ambient AI solutions to reduce documentation burden, improve operational efficiency, and enhance clinician-patient interactions.
The Drug Discovery & Life Sciences segment is expected to register the fastest growth during the forecast period due to increasing utilization of LLMs for target identification, biomarker discovery, clinical trial optimization, and scientific literature analysis. Rising pharmaceutical investments in AI-driven research and the demand for accelerated drug development are significantly driving segment expansion.
The Web & Cloud-based segment held the largest share of the Large Language Models in Healthcare Market due to its scalability, cost-effectiveness, and ease of deployment. Healthcare organizations increasingly prefer cloud-based LLM platforms for clinical documentation, patient engagement, and workflow automation, benefiting from continuous model updates, seamless integration, and reduced infrastructure management requirements.
The On-Premise segment is anticipated to witness the fastest growth during the forecast period, driven by rising concerns regarding data privacy, cybersecurity, and regulatory compliance. Hospitals, government healthcare institutions, and pharmaceutical companies are increasingly adopting on-premise deployments to maintain greater control over sensitive patient information and proprietary healthcare data.
The Hospitals segment dominated the Large Language Models in Healthcare Market due to the extensive adoption of AI-powered clinical documentation, decision support, patient engagement, and administrative automation solutions. Large healthcare systems are increasingly leveraging LLMs to improve care delivery, reduce clinician workload, optimize operational efficiency, and support digital transformation initiatives.
The Pharmaceutical & Biotechnology Companies segment is projected to experience the fastest growth during the forecast period, driven by increasing use of LLMs in drug discovery, clinical trial design, regulatory documentation, and biomedical research. Growing investments in AI-driven innovation and the need to accelerate therapeutic development are fueling rapid segment expansion.
|
By Geography |
2022 |
2025 |
2035 |
|
North America |
XX |
880.8 |
XX |
|
US |
XX |
815.6 |
XX |
|
Canada |
XX |
65.1 |
XX |
|
Europe |
XX |
316.2 |
XX |
|
Germany |
XX |
64.8 |
XX |
|
UK |
XX |
40.4 |
XX |
|
France |
XX |
49.3 |
XX |
|
Italy |
XX |
27.1 |
XX |
|
Spain |
XX |
25.9 |
XX |
|
Switzerland |
XX |
9.8 |
XX |
|
Netherlands |
XX |
6.6 |
XX |
|
Rest of Europe |
XX |
92 |
XX |
|
Asia Pacific |
XX |
262.2 |
XX |
|
China |
XX |
109.8 |
XX |
|
India |
XX |
19.9 |
XX |
|
Japan |
XX |
41.4 |
XX |
|
South Korea |
XX |
37.5 |
XX |
|
Singapore |
XX |
9.4 |
XX |
|
Australia |
XX |
13.6 |
XX |
|
Thailand |
XX |
3.4 |
XX |
|
Malaysia |
XX |
6.5 |
XX |
|
Philippines |
XX |
5.2 |
XX |
|
Indonesia |
XX |
4.1 |
XX |
|
Rest of Asia Pacific |
XX |
11 |
XX |
|
Middle East & Africa |
XX |
46.2 |
XX |
|
Saudi Arabia |
XX |
15.1 |
XX |
|
United Arab Emirates |
XX |
11.9 |
XX |
|
South Africa |
XX |
6.9 |
XX |
|
Egypt |
XX |
3.7 |
XX |
|
Israel |
XX |
4.9 |
XX |
|
Rest of MEA |
XX |
15.1 |
XX |
|
Latin America |
XX |
37 |
XX |
|
Brazil |
XX |
12.1 |
XX |
|
Mexico |
XX |
8.7 |
XX |
|
Argentina |
XX |
3.9 |
XX |
|
Chile |
XX |
3.1 |
XX |
|
Colombia |
XX |
1.9 |
XX |
|
Peru |
XX |
1.5 |
XX |
|
Rest of LA |
XX |
5.5 |
XX |
North America Large Language Models in Healthcare market held the largest share of 57.1% of the global market in 2025 and was valued at approximately USD 880.8 million. Growth is driven by advanced healthcare IT infrastructure, strong AI investments, and widespread deployment of clinical AI solutions.
The U.S. accounted for the dominant share within North America and represented approximately 92.6% of the regional market in 2025. Expansion is fueled by physician documentation automation, robust healthcare AI funding, and increasing integration with EHR systems.
Canada represented approximately 7.4% of the North American market in 2025 and was valued at around USD 65.1 million. Market growth benefits from healthcare digitalization initiatives, virtual care expansion, and growing investments in medical AI innovation.
Europe accounted for approximately 20.5% of the global Large Language Models in Healthcare market in 2025 and was valued at nearly USD 316.2 million. Increasing adoption of digital health technologies, healthcare modernization programs, and AI-driven workflow optimization supports market expansion.
The UK represented approximately 12.8% of the European market in 2025 and was valued at nearly USD 40.4 million. Growth is supported by hospital digitization investments, clinical efficiency initiatives, and rising adoption of AI-enabled healthcare platforms.
Germany accounted for approximately 20.5% of the European market in 2025 and was valued at around USD 64.8 million. Market expansion is driven by NHS digital transformation efforts, AI-assisted care delivery, and healthcare productivity improvements.
The France represented approximately 15.6% of the European market in 2025 and was valued at nearly USD 49.3 million. Growth is supported by healthcare innovation programs, expanding digital infrastructure, and increasing utilization of AI-powered clinical tools.
Italy accounted for approximately 8.6% of the European market in 2025 and was valued at around USD 27.1 million. Rising healthcare modernization initiatives, hospital automation efforts, and demand for operational efficiency drive market growth.
The Spain represented approximately 8.2 % of the European market in 2025 and was valued at nearly USD 25.9 million. Market growth benefits from digital health investments, patient engagement technologies, and increasing adoption of intelligent healthcare systems.
Switzerland accounted for approximately 3.1 % of the European market in 2025 and was valued at around USD 9.8 million. Expansion is supported by advanced healthcare research, precision medicine initiatives, and strong investments in AI-enabled innovation.
The Netherlands represented approximately 2.1 % of the European market in 2025 and was valued at nearly USD 6.6 million. Growth is driven by highly digitized healthcare systems, workflow automation adoption, and expanding AI healthcare applications.
Asia-Pacific accounted for approximately 17% of the global market in 2025 and was valued at nearly USD 262.2 million. Market growth is fueled by rapid healthcare digitalization, growing AI investments, and increasing healthcare data availability.
China represented approximately 41.9 % of the Asia-Pacific market in 2025 and was valued at around USD 109.8 million. Expansion is supported by government-backed AI development, smart hospital initiatives, and large-scale healthcare data ecosystems.
India accounted for approximately 7.6 % of the Asia-Pacific market in 2025 and was valued at nearly USD 19.9 million. Growth is driven by digital health mission programs, telemedicine adoption, and increasing demand for scalable healthcare solutions.
Japan represented approximately 15.8 % of the Asia-Pacific market in 2025 and was valued at around USD 41.4 million. Market expansion benefits from aging population needs, healthcare automation initiatives, and growing investments in clinical AI.
South Korea represented approximately 14.3 % of the Asia-Pacific market in 2025 and was valued at around USD 37.5 million. Growth is supported by smart healthcare infrastructure, AI innovation leadership, and increasing adoption of precision medicine.
Singapore accounted for approximately 3.6 % of the Asia-Pacific market in 2025 and was valued at nearly USD 9.4 million. Expansion is fueled by strong government AI strategies, advanced healthcare ecosystems, and growing digital health innovation.
Australia represented approximately 5.2 % of the Asia-Pacific market in 2025 and was valued at around USD 13.6 million. Market growth is driven by healthcare digitization, remote care expansion, and increasing deployment of AI-enabled solutions.
Thailand represented approximately 1.3 % of the Asia-Pacific market in 2025 and was valued at around USD 3.4 million. Growth benefits from healthcare modernization efforts, medical tourism development, and increasing investments in hospital technologies.
Malaysia accounted for approximately 2.5 % of the Asia-Pacific market in 2025 and was valued at nearly USD 6.5 million. Expansion is supported by digital transformation initiatives, private healthcare investments, and growing adoption of healthcare automation.
Philippines represented approximately 2 % of the Asia-Pacific market in 2025 and was valued at around USD 5.2 million. Market growth is driven by telehealth adoption, healthcare accessibility initiatives, and increasing investments in digital healthcare.
Indonesia represented approximately 1.6 % of the Asia-Pacific market in 2025 and was valued at around USD 4.1 million. Growth is fueled by healthcare infrastructure development, expanding digital health programs, and increasing demand for care accessibility.
Middle East & Africa accounted for approximately 3% of the global market in 2025 and was valued at nearly USD 46.2 million. Expansion is supported by healthcare transformation programs, smart hospital investments, and growing interest in healthcare AI.
Saudi Arabia accounted for approximately 32.8 % of the Middle East market in 2025 and was valued at nearly USD 15.1 million. Growth is driven by Vision 2030 healthcare initiatives, digital transformation projects, and increasing AI technology adoption.
United Arab Emirates represented approximately 25.9 % of the Middle East market in 2025 and was valued at around USD 11.9 million. Market expansion benefits from smart healthcare investments, AI innovation strategies, and growing medical tourism activities.
South Africa represented approximately 15.1 % of the Middle East market in 2025 and was valued at around USD 6.9 million. Growth is supported by healthcare digitization efforts, telemedicine expansion, and increasing demand for efficient care delivery.
Egypt accounted for approximately 8.2 % of the Middle East & Africa market in 2025 and was valued at nearly USD 3.7 million. Expansion is driven by healthcare reform initiatives, digital health adoption, and growing investments in healthcare technologies.
Israel represented approximately 7.2 % of the Middle East and Africa market in 2025 and was valued at around USD 3.3 million. Market growth benefits from a strong healthcare AI ecosystem, advanced research capabilities, and innovation-driven healthcare development.
Latin America accounted for approximately 2.4% of the global market in 2025 and was valued at around USD 37 million. Growth is fueled by healthcare digitalization programs, telehealth expansion, and increasing adoption of AI-enabled healthcare tools.
Brazil accounted for approximately 32.9 % of the Latin America market in 2025 and was valued at nearly USD 12.1 million. Expansion is supported by healthcare modernization efforts, growing private healthcare investments, and rising digital health adoption.
Mexico accounted for approximately 23.5 % of the Latin America market in 2025 and was valued at nearly USD 8.7 million. Market growth is driven by healthcare transformation programs, operational efficiency initiatives, and increasing AI technology deployment.
Argentina represented approximately 10.6 % of the Latin America market in 2025 and was valued at around USD 3.9 million. Growth benefits from expanding digital health adoption, healthcare efficiency requirements, and increasing AI research activities.
Chile represented approximately 8.6 % of the Latin America market in 2025 and was valued at around USD 3.1 million. Expansion is supported by government digital health initiatives, healthcare analytics adoption, and connected care developments.
Colombia accounted for approximately 5.2 % of the Latin America market in 2025 and was valued at nearly USD 1.9 million. Market growth is fueled by healthcare digitization investments, telemedicine expansion, and increasing adoption of patient engagement solutions.
Peru represented approximately 4.3 % of the Latin America market in 2025 and was valued at around USD 1.5 million. Growth is driven by healthcare infrastructure improvements, digital transformation initiatives, and rising demand for healthcare accessibility.
|
Company |
Share |
|
OpenAI |
16.8% |
|
Microsoft |
14.2% |
|
Google DeepMind |
11.6% |
|
Oracle |
8.4% |
|
Anthropic |
6.7% |
Our research framework strategically segments the Large Language Models in Healthcare market by Component, Application, Deployment Mode, End Use and key regional markets
By Component
By Application
By Deployment Mode
By End Use
By Region & Country
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
|
Key Report Attributes |
Details |
|
Years Considered |
2022 to 2035 |
|
Market Size 2025 |
USD 1542.6 Million |
|
Market Size 2035 |
USD 26917.4 Million |
|
Historical CAGR % (Growth rate) |
XX% from 2022 to 2025 |
|
Futuristic CAGR % (Growth rate) |
33.1% from 2026 to 2035 |
|
Segments Covered |
· By Component · By Application · By Deployment Mode · By End-Use |
|
Regions Covered |
· North America · Europe · Asia Pacific · Latin America · Middle East & Africa |
|
Countries Covered |
USA; Canada; Germany; United Kingdom; France; Italy; Spain; Switzerland; Netherlands; China; India; Japan; South Korea; Singapore; Australia; Thailand; Malaysia; Philippines; Indonesia; Saudi Arabia; United Arab Emirates; South Africa; Egypt; Israel; Brazil; Mexico; Argentina; Chile; Colombia; Peru |
|
Competitive Landscape Overview |
· MedGPT · OpenAI · Google DeepMind · Microsoft · Oracle · Certilytics · John Snow Labs · Merative · Anthropic · Meta AI · Hippocratic AI · Ambience Healthcare · Abridge AI, Inc. · Tempus AI · Aidoc · Viz.ai · Qure.ai · PathAI · Insilico Medicine · Owkin · Benevolent AI |
|
Flexible Report Customization |
The study can be customized based on geography, segment analysis, company profiling, competitive benchmarking, and strategic insights. |
|
Data Sources |
Primary and secondary sources used (Company filings, trade associations, Journals, Annual report, Publications, Surveys, Investor Presentations, and much more. |
By Component
By Application
By Deployment Mode
By End Use
+44 1313818849
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
INDIA OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
408B, City Center, Hadapsar, Pune, India 411028
FOLLOW US
© Copyright 2026-27 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®